$ATRA Atara Biotherapeutics, Inc. Insider Trading Week 20/2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Atara Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Atara Biotherapeutics, Inc. in week 20/2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 7,698 | 0 | 20,526 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 935 | 0 | 0 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 15.27 | 2,000 | 30,540 | 117,460 | 119.5 K to 117.5 K (-1.67 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 14.95 | 2,000 | 29,900 | 119,460 | 121.5 K to 119.5 K (-1.65 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 7,698 | 0 | 121,460 | 113.8 K to 121.5 K (+6.77 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 935 | 0 | 113,762 | 112.8 K to 113.8 K (+0.83 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 817 | 0 | 2,997 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Option Exercise | M | 0.00 | 1,549 | 0 | 4,645 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Sell | S | 15.25 | 1,184 | 18,056 | 103,374 | 104.6 K to 103.4 K (-1.13 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 817 | 0 | 104,558 | 103.7 K to 104.6 K (+0.79 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Gallagher Carol Giltner | Director | Buy | M | 0.00 | 1,549 | 0 | 103,741 | 102.2 K to 103.7 K (+1.52 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,908 | 0 | 15,754 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Ciechanover Isaac E. | Chief Executive Off ... | Buy | M | 0.00 | 5,908 | 0 | 731,859 | 726 K to 731.9 K (+0.81 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Option Exercise | M | 0.00 | 829 | 0 | 2,211 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Sell | S | 14.99 | 7,604 | 113,984 | 374,080 | 381.7 K to 374.1 K (-1.99 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Haqq Christopher | EVP, R&D & Chief Sc ... | Buy | M | 0.00 | 829 | 0 | 381,684 | 380.9 K to 381.7 K (+0.22 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Option Exercise | M | 0.00 | 7,212 | 0 | 26,442 | |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Sell | S | 15.25 | 3,873 | 59,063 | 153,000 | 156.9 K to 153 K (-2.47 %) |
| May 17 2017 | ATRA | Atara Biotherapeut ... | Clark Mitchall G. | EVP & Chief R & QA ... | Buy | M | 0.00 | 7,212 | 0 | 156,873 | 149.7 K to 156.9 K (+4.82 %) |